References
- Goutopoulos A, Makriyannis A. From cannabis to cannabinergics: new therapeutic opportunities. Pharmacol Ther 2002;95:103–117.
- Goutopoulos A, Fan P, Khanolkar AD, Xie XQ, Lin S, Makriyannis A. Stereochemical selectivity of methanandamides for the CB1 and CB2 cannabinoid receptors and their metabolic stability. Bioorg Med Chem 2001;9:1673–1684.
- Khanolkar AD, Abadji V, Lin S, Hill WA, Taha G, Abouzid K et al. Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand. J Med Chem 1996;39:4515–4519.
- Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993;365:61–65.
- Wiley JL, Martin BR. Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes. Chem Phys Lipids 2002;121:57–63.
- Joong Y S. Understanding functional residues of the cannabinoid CB1 receptor for drug discovery. Current Topics in Med Chem 2010;10:779–798.
- Pasquini L, Botta T, Semeraro C, Mugnaini A, Ligresti E, Palazzo S, Maione V, Di Marzo F. Three-dimensional quantitative structure selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor CB2. J. Med Chem 2008;51:5075–5084.
- Steven G, Kinsey a, Anu Mahadevan b, Bingjun Z, Hang S, Pattipati S, Naidu R, Razdan K, Dana E, Selley M, Imad D, Aron L. The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects. Neuropharm 2011;60:244–251.
- Noha A, Osman A, Mahmoud H, Marco A, Raimund N, Khaled A, Abouzid Vincenzo, M, Ashraf A. Synthesis, binding studies and molecular modeling of novel cannabinoid receptor ligands. Bioorg Med Chem 2010;18:8463–8477.
- Olpp T. Product class 2: 2-oxoaldehydes and heteroatom analogues. Science of Synth 2007;25:423–439.
- Tran Q, Nguyen D. Synthesis and structures of some 6-(2-arylvinyl)-4,5-dihydropyridazin-3(2H)-ones. Tap Chi Hoa Hoc 2004;42:325–328. Through CA 143:347118.
- Passarotti C, Fossati A, Bandi L, Bozzi R, Vimercati G, Galmozzi G, Fabris L, Movalli A, Cerrati A. Synthesis and antiinflammatory activity of some E-ketophenylalkenoic carboxylic acids. Act Toxia Therap 1988;9:289–296.
- Gluzman M, Mil’ner S. Investigation of the acylation process of amines by solid succinic and benzoic anhydrides under isothermal conditions. Khim Khimich Tekhno 1960;3:684–690.
- Giuseppina C, Ernesto F, Orazio S, Giorgio B, Henny A, Dien A, Ligresti V, Di M. Desulfohaplosamate a new phosphate-containing steroid from Dasychalina sp., is a selective cannabinoid CB2 receptor ligand. Steroids 2011;76:998–1002.
- Pasquini S, Botta L, Semeraro T, Mugnaini C, Ligresti A, Palazzo E et al. Investigations on the 4-quinolone-3-carboxylic acid motif. 2. Synthesis and structure-activity relationship of potent and selective cannabinoid-2 receptor agonists endowed with analgesic activity in vivo. J Med Chem 2008;51:5075–5084.
- Brizzi A, Brizzi V, Cascio MG, Bisogno T, Sirianni R, Di Marzo V. Design, synthesis, and binding studies of new potent ligands of cannabinoid receptors. J Med Chem 2005;48:7343–7350.
- Ismail M, Lehmann J, Abou El ella D, Albohy A, Abouzid K.. Lonazolac analogues: molecular modeling, synthesis and in vivo anti-inflammatory activity. Med Chem Res 2009;18:725–744.